Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Cytek Biosciences, Inc. provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that deliver cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The company also provides reagents and kits, including cFluor reagents.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $710,000.00 | $2.2M | $3.0M | $193.0M | $200.5M | $201.5M |
| Gross profit | $51.7M | $79.1M | $101.0M | $109.4M | $111.1M | $104.5M |
| Operating income | $13.7M | $9.2M | -$1.8M | -$27.8M | -$20.5M | -$40.4M |
| Net income | $19.4M | $3.0M | $2.5M | -$12.1M | -$6.0M | -$66.5M |
| Diluted EPS | $0.10 | $0.00 | $0.02 | -$0.09 | — | — |
| Operating cash flow | $15.2M | $4.6M | -$12.2M | $5.3M | $25.4M | -$4.7M |
| Free cash flow | $13.6M | $266,000.00 | -$22.0M | $633,000.00 | $21.9M | -$8.8M |
| Gross margin | 7283.1% | 3628.8% | 3407.8% | 56.7% | 55.4% | 51.8% |
| Operating margin | 1923.8% | 419.9% | -60.9% | -14.4% | -10.2% | -20.0% |
| Net margin | 2733.9% | 138.8% | 83.8% | -6.3% | -3.0% | -33.0% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $46.6M | $51.5M | $57.5M | $41.5M | $45.6M | $52.3M | $62.1M | $44.1M |
| Gross profit | $25.4M | $29.0M | $33.7M | $20.2M | $23.9M | $27.6M | $32.9M | $21.3M |
| Operating income | -$8.5M | -$4.2M | $3.0M | -$15.0M | -$10.6M | -$9.2M | -$5.6M | -$18.5M |
| Net income | — | — | — | -$11.4M | — | — | — | -$18.9M |
| Diluted EPS | — | — | — | — | — | — | — | — |
| Operating cash flow | $6.2M | $13.2M | $2.0M | -$125,000.00 | $108,000.00 | -$3.9M | -$771,000.00 | -$2.7M |
| Free cash flow | $5.2M | $12.2M | $1.1M | -$974,000.00 | -$1.5M | -$4.6M | -$1.8M | -$4.9M |
| Gross margin | 54.6% | 56.3% | 58.5% | 48.6% | 52.3% | 52.7% | 52.9% | 48.2% |
| Operating margin | -18.3% | -8.2% | 5.2% | -36.1% | -23.3% | -17.6% | -9.0% | -41.8% |
| Net margin | — | — | — | -27.5% | — | — | — | -42.7% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-12 | Yan Ming· CHIEF TECHNOLOGY OFFICER | Gift | 135,892 | $0.00 | $0.00 | filing |
| 2026-06-10 | Ball Jack | Option exercise | 43,973 | — | — | filing |
| 2026-06-10 | Imper Vera | Option exercise | 43,973 | — | — | filing |
| 2026-06-10 | Holder Michael | Option exercise | 43,973 | — | — | filing |
| 2026-06-10 | NEFF DEBORAH J | Option exercise | 43,973 | — | — | filing |
| 2026-05-18 | Jiang Wenbin· PRESIDENT AND CEO | Tax withholding | 15,009 | $3.55 | $53,281.95 | filing |
| 2026-05-18 | Jiang Wenbin· PRESIDENT AND CEO | Tax withholding | 5,032 | $3.55 | $17,863.60 | filing |
| 2026-05-18 | McCombe William D.· Chief Financial Officer | Tax withholding | 3,839 | $3.55 | $13,628.45 | filing |
| 2026-05-18 | Jiang Wenbin· PRESIDENT AND CEO | Tax withholding | 3,588 | $3.55 | $12,737.40 | filing |
| 2026-05-18 | Barnett Valerie· CHIEF LEGAL OFFICER | Tax withholding | 3,386 | $3.55 | $12,020.30 | filing |
| 2026-05-18 | McCombe William D.· Chief Financial Officer | Tax withholding | 3,122 | $3.55 | $11,083.10 | filing |
| 2026-05-18 | Barnett Valerie· CHIEF LEGAL OFFICER | Tax withholding | 2,602 | $3.55 | $9,237.10 | filing |
| 2026-05-18 | Yan Ming· CHIEF TECHNOLOGY OFFICER | Tax withholding | 2,364 | $3.55 | $8,392.20 | filing |
| 2026-05-18 | McCombe William D.· Chief Financial Officer | Tax withholding | 2,268 | $3.55 | $8,051.40 | filing |
| 2026-05-18 | Jiang Wenbin· PRESIDENT AND CEO | Tax withholding | 1,913 | $3.55 | $6,791.15 | filing |
| 2026-05-18 | Barnett Valerie· CHIEF LEGAL OFFICER | Tax withholding | 1,850 | $3.55 | $6,567.50 | filing |
| 2026-05-18 | Busque Philippe· SVP, GLOBAL SALES AND SERVICES | Tax withholding | 1,424 | $3.55 | $5,055.20 | filing |
| 2026-05-18 | Yan Ming· CHIEF TECHNOLOGY OFFICER | Tax withholding | 1,224 | $3.55 | $4,345.20 | filing |
| 2026-05-18 | Yan Ming· CHIEF TECHNOLOGY OFFICER | Tax withholding | 1,025 | $3.55 | $3,638.75 | filing |
| 2026-05-18 | Yan Ming· CHIEF TECHNOLOGY OFFICER | Tax withholding | 919 | $3.55 | $3,262.45 | filing |
| 2026-05-18 | Barnett Valerie· CHIEF LEGAL OFFICER | Tax withholding | 881 | $3.55 | $3,127.55 | filing |
| 2026-05-18 | Busque Philippe· SVP, GLOBAL SALES AND SERVICES | Tax withholding | 620 | $3.55 | $2,201.00 | filing |
| 2026-05-18 | Busque Philippe· SVP, GLOBAL SALES AND SERVICES | Tax withholding | 378 | $3.55 | $1,341.90 | filing |
| 2026-05-18 | Busque Philippe· SVP, GLOBAL SALES AND SERVICES | Tax withholding | 263 | $3.55 | $933.65 | filing |
| 2026-05-18 | Jiang Wenbin· PRESIDENT AND CEO | Option exercise | 14,733 | — | — | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.